Product Name

  • Name

    Diphenolic acid

  • EINECS 204-763-2
  • CAS No. 126-00-1
  • Article Data13
  • CAS DataBase
  • Density 1.26 g/cm3
  • Solubility Soluble in acetic acid, acetone, ethanol, insoluble in benzene, carbon tetrachloride and dimethyl benzene, slightly soluble in water
  • Melting Point 167-170 °C(lit.)
  • Formula C17H18O4
  • Boiling Point 507 °C at 760 mmHg
  • Molecular Weight 286.328
  • Flash Point 274.5 °C
  • Transport Information
  • Appearance Light brown particles
  • Safety 26-37/39-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 126-00-1 (Diphenolic acid)
  • Hazard Symbols IrritantXi
  • Synonyms Valericacid, 4,4-bis(p-hydroxyphenyl)- (6CI,8CI);4,4-Bis(4-hydroxyphenyl)pentanicacid;4,4-Bis(4-hydroxyphenyl)pentanoic acid;4,4-Bis(4-hydroxyphenyl)valericacid;4,4-Bis(p-hydroxyphenyl)pentanoic acid;4,4-Bis(p-hydroxyphenyl)valericacid;4,4'-Bis(4-hydroxyphenyl)valeric acid;Bisphenol acid;DPA;NSC 3371;NSC 55069;γ,γ-Bis(p-hydroxyphenyl)valeric acid;
  • PSA 77.76000
  • LogP 3.26860

Synthetic route

levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Conditions
ConditionsYield
With sulfuric acid
With hydrogenchloride
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Sealed tube; Inert atmosphere; Schlenk technique;91 mol
4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

methyl iodide
74-88-4

methyl iodide

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

4,4-bis(4'-methoxyphenyl)pentanoic acid
111161-78-5

4,4-bis(4'-methoxyphenyl)pentanoic acid

C

(4'-hydroxyphenyl)-4-(4''-methoxyphenyl)pentanoic acid

(4'-hydroxyphenyl)-4-(4''-methoxyphenyl)pentanoic acid

Conditions
ConditionsYield
With potassium hydroxide; cobalt(II) acetate; silver(l) oxide Product distribution; multistepreaction, degradative method for the determination of the degree of branching for hyperbranched macromolecules;
water
7732-18-5

water

levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

mineral acid

mineral acid

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-oxopentanoic acid ethyl ester
539-88-8

4-oxopentanoic acid ethyl ester

phenol
108-95-2

phenol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Conditions
ConditionsYield
With sulfuric acid In water at 0 - 20℃; for 18h; Condensation;
levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

C17H18O4
1033556-25-0

C17H18O4

Conditions
ConditionsYield
With ethanethiol at 99.84℃; for 16h; Inert atmosphere;
With C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Temperature; Time; Concentration; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 75 mol;
4-oxopentanoic acid ethyl ester
539-88-8

4-oxopentanoic acid ethyl ester

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

ethyl diphenolate
7297-86-1

ethyl diphenolate

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 80 mol;A 22 mol
B 58 mol
levulinic acid methyl ester
624-45-3

levulinic acid methyl ester

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 79 mol;A 22 mol
B 57 mol
butyl levulinate
2052-15-5

butyl levulinate

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

butyl diphenolate
7297-88-3

butyl diphenolate

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 81 mol;A 16 mol
B 65 mol
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 8h; Fischer-Speier Esterification; Reflux;99%
With sulfuric acid for 3h; Esterification; Heating;97%
for 2h; Reflux;96%
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With p-toluenesulfonic acid monohydrate for 16h; Reflux;98%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol for 16h; Reflux;98%
formaldehyd
50-00-0

formaldehyd

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,3,5-triphenylhexahydro-1,3,5-triazine
91-78-1

1,3,5-triphenylhexahydro-1,3,5-triazine

4,4-bis[3-phenyl-3,4-dihydro-2H-1,3-benzoxazin-6-yl]pentanoic acid
918303-70-5

4,4-bis[3-phenyl-3,4-dihydro-2H-1,3-benzoxazin-6-yl]pentanoic acid

Conditions
ConditionsYield
In toluene at 110℃; for 6h;95%
In toluene at 110℃; for 6h;94.8%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

phosphazene base-P4-tert-butyl
111324-04-0

phosphazene base-P4-tert-butyl

C17H18O4*C22H63N13P4
1370263-33-4

C17H18O4*C22H63N13P4

Conditions
ConditionsYield
In tetrahydrofuran; hexane at 20℃; for 12h; Inert atmosphere;95%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

N-methyl piperazine diphenolamide

N-methyl piperazine diphenolamide

Conditions
ConditionsYield
at 160 - 180℃; Inert atmosphere;95%
at 80 - 180℃; Inert atmosphere;85%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

benzyl chloride
100-44-7

benzyl chloride

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate
184866-14-6

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate In acetone for 72h; Heating;90%
ethanol
64-17-5

ethanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

ethyl diphenolate
7297-86-1

ethyl diphenolate

Conditions
ConditionsYield
With sulfuric acid for 16h; Fischer-Speier Esterification; Reflux;85%
at 40℃; for 8h; Sealed tube; Inert atmosphere; Schlenk technique;83 mol
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

9-bromoethylanthracene
2417-77-8

9-bromoethylanthracene

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: 9-bromoethylanthracene In N,N-dimethyl-formamide at 80℃; for 2h;
84%
anthracenylmethyl chloride
24463-19-2

anthracenylmethyl chloride

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: anthracenylmethyl chloride In N,N-dimethyl-formamide at 80℃; for 5h;
84%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

benzyl bromide
100-39-0

benzyl bromide

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate
184866-14-6

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetone Reflux;83.5%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

(9H-fluoren-9-yl)methyl (S)-(2-amino-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-amino-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-(4,4-bis(4-hydroxyphenyl)pentanamido)-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-(4,4-bis(4-hydroxyphenyl)pentanamido)-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;83%
2-bromoisobutyric acid bromide
20769-85-1

2-bromoisobutyric acid bromide

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4,4-bis-[4-(2-bromo-2-methyl-propionyloxy)-phenyl]-pentanoic acid

4,4-bis-[4-(2-bromo-2-methyl-propionyloxy)-phenyl]-pentanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran for 48h;82%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

desipramine hydrochloride
58-28-6

desipramine hydrochloride

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)-N-methylpentanamide

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)-N-methylpentanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;82%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-(hydroxymethyl)-1-oxido-2,6,7-trioxa-1-phosphabicyclo [2.2.2] octane
5301-78-0

4-(hydroxymethyl)-1-oxido-2,6,7-trioxa-1-phosphabicyclo [2.2.2] octane

C22H25O8P

C22H25O8P

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetonitrile at 70℃; for 24h; Inert atmosphere;80.2%
With toluene-4-sulfonic acid In acetonitrile for 24h; Inert atmosphere; Reflux;55%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate
30833-12-6

ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate

N-ethoxycarbonyl diphenylglycol acetate

N-ethoxycarbonyl diphenylglycol acetate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 30℃; for 2.5h;
Stage #2: ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate With dmap In dichloromethane at 25 - 30℃; for 3.5h;
80%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

tert-butyl alcohol
75-65-0

tert-butyl alcohol

tert-butyl 4,4-bis(4'-hydroxyphenyl)pentanoate
138721-52-5

tert-butyl 4,4-bis(4'-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With trifluoroacetic anhydride In tetrahydrofuran at 5 - 20℃; for 2.5h;
Stage #2: tert-butyl alcohol In tetrahydrofuran at 20℃; for 6h;
71.1%
tetrakis[bis(trimethylsilyl)methyl]digallane(4)
125370-09-4

tetrakis[bis(trimethylsilyl)methyl]digallane(4)

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Ga2(CH(SiMe3)2)2(4,4-bis(4-hydroxyphenyl)valerate)2
1258211-74-3

Ga2(CH(SiMe3)2)2(4,4-bis(4-hydroxyphenyl)valerate)2

Conditions
ConditionsYield
In tetrahydrofuran digallium compd. and acid suspended in THF at room temp.; suspn. stirred at room temp. for 16 h; volatiles removed in vacuo; residue washed with n-pentane;66%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

4,4-bis-(4-hydroxy-phenyl)-pentanoic acid 3-bromo-propyl ester
848599-31-5

4,4-bis-(4-hydroxy-phenyl)-pentanoic acid 3-bromo-propyl ester

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: 1,3-dibromo-propane In N,N-dimethyl-formamide at 80℃; for 5h;
65%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4,4-bis-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-pentanoic acid

4,4-bis-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-pentanoic acid

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate65%
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2-(chloromethyl)quinoline monohydrochloride
3747-74-8

2-(chloromethyl)quinoline monohydrochloride

A

4,4-bis(3-chloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester
189498-99-5

4,4-bis(3-chloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

B

4-(3-chloro-4-(2-quinolylmethoxy)phenyl)-4-(3,5-dichloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

4-(3-chloro-4-(2-quinolylmethoxy)phenyl)-4-(3,5-dichloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With N-chloro-succinimide In 1,4-dioxane; chloroform for 5h; Chlorination; Heating;
Stage #2: methanol With thionyl chloride at 20℃; for 16h; Esterification;
Stage #3: 2-(chloromethyl)quinoline monohydrochloride With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 10h; Alkylation; Further stages.;
A 61%
B 9%
Diethyl iminodiacetate
6290-05-7

Diethyl iminodiacetate

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

{[4,4-bis-(4-hydroxyphenyl)-pentanoyl]-ethoxycarbonyl-methylamino}-acetic acid ethyl ester
625833-52-5

{[4,4-bis-(4-hydroxyphenyl)-pentanoyl]-ethoxycarbonyl-methylamino}-acetic acid ethyl ester

Conditions
ConditionsYield
With 2-chloro-1-methyl-pyridinium iodide; triethylamine In 1,4-dioxane at 70℃; for 0.166667 - 0.333333h;56%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

(9H-fluoren-9-yl)methyl (2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)amino)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)amino)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-(N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)pentanamido)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-(N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)pentanamido)ethyl)carbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;48%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine
165749-18-8

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine

N-(3,4-bis((tert-butyldimethylsilyl)oxy)phenethyl)-4,4-bis(4-hydroxyphenyl)pentanamide

N-(3,4-bis((tert-butyldimethylsilyl)oxy)phenethyl)-4,4-bis(4-hydroxyphenyl)pentanamide

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In ethyl acetate at 20℃; for 3h; Inert atmosphere;46%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

dibenzylamine
103-49-1

dibenzylamine

4,4-Bis-(4-hydroxyphenyl)pentanoic acid dibenzylamide
188108-07-8

4,4-Bis-(4-hydroxyphenyl)pentanoic acid dibenzylamide

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water; ethyl acetate40%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C23H32O4Si
1219458-16-8

C23H32O4Si

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid; tert-butyldimethylsilyl chloride With 1H-imidazole In tetrahydrofuran for 12h; Reflux;
Stage #2: With acetic acid In water at 20℃; for 2h;
40%
6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid
159610-89-6

6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid

O-bis-(aminoethyl)ethylene glycol trityl resin

O-bis-(aminoethyl)ethylene glycol trityl resin

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide
1623789-42-3

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-[4,4-bis(4-hydroxyphenyl)pentanoyl]-β-aspartyl-β-aspartyl-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-6-(4-{4-oxo-4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino]butyl}-1H-1,2,3-triazol-1-yl)-L-norleucinamide

N-[4,4-bis(4-hydroxyphenyl)pentanoyl]-β-aspartyl-β-aspartyl-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-6-(4-{4-oxo-4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino]butyl}-1H-1,2,3-triazol-1-yl)-L-norleucinamide

Conditions
ConditionsYield
Stage #1: 6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid; O-bis-(aminoethyl)ethylene glycol trityl resin With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 22℃; for 1.25h; trityl resin;
Stage #2: With piperidine In N,N-dimethyl-formamide
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide; Fmoc-Asp-O-t-Bu Further stages;
38%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2,5-dioxopyrrolidin-1-yl-4,4-bis(4-hydroxyphenyl)pentanoate
1445510-01-9

2,5-dioxopyrrolidin-1-yl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 22h;36%
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 1h;250 mg
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide
1623789-42-3

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide

Boc-Lys(Fmoc)-OH
84624-27-1

Boc-Lys(Fmoc)-OH

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine
103213-32-7

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine

C52H70N14O19S3

C52H70N14O19S3

Conditions
ConditionsYield
Stage #1: N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine With piperidine In N,N-dimethyl-formamide for 0.25h;
Stage #2: Fmoc-(tBu)Asp-OH With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 1.25h;
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; Fmoc-Leu-OH; N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide; Boc-Lys(Fmoc)-OH; Fmoc-Asp-O-t-Bu Further stages;
22%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

5-hexynoic amide
21233-94-3

5-hexynoic amide

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine
103213-32-7

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

NH2+-ValCit-MMAE

NH2+-ValCit-MMAE

Conditions
ConditionsYield
Stage #1: N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine With piperidine In N,N-dimethyl-formamide for 0.25h;
Stage #2: Fmoc-(tBu)Asp-OH With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 1.25h;
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; Fmoc-Leu-OH; 5-hexynoic amide; Fmoc-Asp-O-t-Bu; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages;
11%

Diphenolic acid Specification

The Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-, with the CAS registry number 126-00-1, is also known as 4,4-Bis(p-hydroxyphenyl)valericacid. Its EINECS number is 204-763-2. This chemical's molecular formula is C17H18O4 and molecular weight is 286.32. What's more, its systematic name is 4,4-bis(4-hydroxyphenyl)pentanoic acid. It is used as a pharmaceutical intermediate and widely used in food, medicine, chemical industry, light industry and other industries.

Physical properties of Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl- are: (1)ACD/LogP: 2.89; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.97; (4)ACD/LogD (pH 7.4): 0.17; (5)ACD/BCF (pH 5.5): 11.25; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 108.06; (8)ACD/KOC (pH 7.4): 1.69; (9)#H bond acceptors: 4; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 7; (12)Polar Surface Area: 44.76 Å2; (13)Index of Refraction: 1.612; (14)Molar Refractivity: 78.99 cm3; (15)Molar Volume: 227.2 cm3; (16)Polarizability: 31.31×10-24cm3; (17)Surface Tension: 55.8 dyne/cm; (18)Density: 1.26 g/cm3; (19)Flash Point: 274.5 °C; (20)Enthalpy of Vaporization: 81.82 kJ/mol; (21)Boiling Point: 507 °C at 760 mmHg; (22)Vapour Pressure: 4.21E-11 mmHg at 25°C.

Preparation: the crude product can be prepared by levulinic acid and phenol in the presence of catalyst, in acid medium reaction system, then refinined to the finished product.

Uses of Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-: it can be used to produce 4,4-bis-(4-hydroxy-phenyl)-valeric acid methyl ester by heating. It will need reagent conc. H2SO4 with the reaction time of 3 hours. The yield is about 97%.

Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl- can be used to produce 4,4-bis-(4-hydroxy-phenyl)-valeric acid methyl ester by heating

When you are using this chemical, please be cautious about it as the following:
It is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(O)CCC(c1ccc(O)cc1)(c2ccc(O)cc2)C
(2)Std. InChI: InChI=1S/C17H18O4/c1-17(11-10-16(20)21,12-2-6-14(18)7-3-12)13-4-8-15(19)9-5-13/h2-9,18-19H,10-11H2,1H3,(H,20,21)
(3)Std. InChIKey: VKOUCJUTMGHNOR-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View